News
Important Only
Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
July 21 (Reuters) - Autolus Therapeutics PLC 6A3Ay.F:AUTOLUS THERAPEUTICS’ CAR T THERAPY AUCATZYL® (OBECABTAGENE AUTOLEUCEL) GRANTED EUROPEAN MARKETING AUTHORIZATION FOR ADULT PATIENTS (AGE 26 AND OLDER) WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL)Further com...Reuters
Mon, Jul 21
Bioxcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package In Support Of Potential Label Expansion For Igalmi
July 21 (Reuters) - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS SUBMITS PRE-SUPPLEMENTAL NEW DRUG APPLICATION MEETING PACKAGE IN SUPPORT OF POTENTIAL LABEL EXPANSION FOR IGALMI®BIOXCEL THERAPEUTICS INC - PRE-SNDA MEETING WITH FDA SCHEDULED FOR AUGUST 20, 2025Reuters
Mon, Jul 21
Stellantis CEO Filosa promises gradual recovery after first half loss
MILAN, July 21 (Reuters) - Stellantis' STLAM.MI new Chief Executive Antonio Filosa said on Monday that 2025 would be "a year of gradual and sustainable improvement" for the automaker, after it posted a preliminary 2.3 billion euro ($2.7 billion) net loss for the first half.In a letter to...Reuters
Mon, Jul 21
Oruka Therapeutics Announces Ind Clearance For Everlast-A Phase 2A Trial Of Orka-001 In Psoriasis With Phase 1 Data To Be Presented At Eadv In September
July 21 (Reuters) - Oruka Therapeutics Inc ORKA.O:ORUKA THERAPEUTICS ANNOUNCES IND CLEARANCE FOR EVERLAST-A PHASE 2A TRIAL OF ORKA-001 IN PSORIASIS WITH PHASE 1 DATA TO BE PRESENTED AT EADV IN SEPTEMBERORUKA THERAPEUTICS: IND CLEARED FOR EVERLAST-A PHASE 2A TRIAL OF ORKA-001 IN MODERATE-TO-SEVERE PS...Reuters
Mon, Jul 21
PCB Bancorp expected to post earnings of 56 cents a share - Earnings Preview
PCB Bancorp PCB.OQ PCB.O is expected to show a rise in quarterly revenue when it reports results on July 23 (estimated) for the period ending June 30 2025The Los Angeles California-based company is expected to report a 18.5% increase in revenue to $28.7 million from $24.22 million a year ago, acc...Reuters
Mon, Jul 21
S&P Dow Jones Indices To Acquire Arc Research, Expanding Wealth Data And Benchmarking Capabilities
July 21 (Reuters) - S&P Global Inc SPGI.N:S&P DOW JONES INDICES TO ACQUIRE ARC RESEARCH, EXPANDING WEALTH DATA AND BENCHMARKING CAPABILITIESS&P GLOBAL INC: FINANCIAL TERMS OF THIS DEAL WERE NOT DISCLOSEDReuters
Mon, Jul 21
Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
July 21 (Reuters) - Compugen Ltd CGEN.TA:COMPUGEN ANNOUNCES FIRST PATIENT DOSED IN COM701 GLOBAL PLATFORM TRIAL IN PLATINUM SENSITIVE OVARIAN CANCERCOMPUGEN LTD - INTERIM ANALYSIS OF COM701 TRIAL PLANNED FOR 2026Reuters
Mon, Jul 21
Monte Rosa Therapeutics Announces First Subjects Dosed In Phase 1 Study Of Mrt-8102, A Nek7-Directed Molecular Glue Degrader For The Treatment Of Multiple Inflammatory Diseases
July 21 (Reuters) - Monte Rosa Therapeutics Inc GLUE.O:MONTE ROSA THERAPEUTICS ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 STUDY OF MRT-8102, A NEK7-DIRECTED MOLECULAR GLUE DEGRADER FOR THE TREATMENT OF MULTIPLE INFLAMMATORY DISEASESMONTE ROSA THERAPEUTICS INC - INITIAL RESULTS FROM PHASE 1 STUDY EXPE...Reuters
Mon, Jul 21
Bristol Myers Squibb’S Supplemental New Drug Application (SNDA) For Sotyktu (Deucravacitinib) Accepted for Review Across Four Regions
July 21 (Reuters) - Bristol-Myers Squibb Co BMY.N:BRISTOL MYERS SQUIBB’S SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR SOTYKTU (DEUCRAVACITINIB) FOR THE TREATMENT OF ADULTS WITH ACTIVE PSORIATIC ARTHRITIS ACCEPTED FOR REVIEW ACROSS FOUR REGIONS GLOBALLYBRISTOL-MYERS SQUIBB CO - FDA TARGET ACTION DATE...Reuters
Mon, Jul 21
Verizon boosts annual profit forecast on demand for premium plans
July 21 (Reuters) - Verizon raised the lower end of its annual profit forecast on Monday, as strong demand for its higher-tier plans powered better-than-expected earnings in the second quarter.The U.S. telecom major VZ.N posted a 2.2% rise in wireless service revenue as more users opted for its add-...Reuters
Mon, Jul 21
Kremlin doesn't rule out a Putin-Trump meeting in Beijing in September
MOSCOW, July 21 (Reuters) - The Kremlin said on Monday that it did not rule out the possibility of a meeting between Vladimir Putin and Donald Trump if the Russian and U.S. presidents were both in Beijing at the same time in September.Kremlin spokesman Dmitry Peskov confirmed that Putin would visit ...Reuters
Mon, Jul 21
Ryanair decides against switching MAX 10 order after Boeing offers reassurances
DUBLIN, July 21 (Reuters) - Ryanair RYA.I has decided not to switch MAX 10 aircraft due for delivery in early 2027 to the smaller MAX 8 aircraft following reassurances from Boeing BA.N that they will arrive on time, Chief Executive Michael O'Leary said on Monday. Boeing promised to tell Ryanair ...Reuters
Mon, Jul 21
Trump officials to visit Fed amid renovation probe, Semafor reports
July 21 (Reuters) - U.S. President Donald Trump's administration wants to visit the Federal Reserve's Washington headquarters this week to review its $2.5 billion renovation, Semafor reported on Monday, citing White House Deputy Chief of Staff James Blair. Senate Banking Chair Tim Scott is i...Reuters
Mon, Jul 21
